MEF2B Antilichaam - middengebied: FITC (ARP38697_P050-FITC)

BORCS8-MEF2B readthrough

MEF2B, RSRFR2, MEF2BNB-MEF2B, LOC729991-MEF2B

4207

Q02080

NP_005910

Human

The immunogen is a synthetic peptide directed towards the middle region of human MEF2B

This gene represents numerous read-through transcripts that span GeneID:729991 and 100271849. Many read-through transcripts are predicted to be nonsense-mediated decay (NMD) candidates, and are thought to be non-coding. Some transcripts are predicted to be capable of translation reinitiation at a downstream AUG, resulting in expression of at least one isoform of myocyte enhancer factor 2B (MEF2B) from this read-through locus. At least one additional MEF2B variant and isoform can be expressed from a downstream promoter, and is annotated on GeneID:100271849.

TEX11; CABIN1; UBC

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

0.5 mg/ml

Human: 100%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

39kDa

Gong, X., (er) BMC Mol. Biol. 7, 7 (2006)

Wet Ice

365

MEF2B

MEF2B

Rabbit

Myocyte enhancer factor 2B

NM_005919

GLGPPCAGCPWPTAGPGRRSPGGTSPERSPGTARARGDPTSLQASSEKTQ